Access Industries Holdings LLC
CIK 1391297 · last filed 2026-05-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WMG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
730 FIFTH AVENUE, 20TH FLOOR
NEW YORK, NY 10019
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DOCN | 119,587 | $78.30 | $9.36M | -$495.99M | 1 | 2026-05-15 | |
| IRON | 10%+ Owner | 2,814,379 | $81.26 | $228.70M | -$59.87M | 2 | 2025-10-24 |
| WMG | 318,536 | $31.79 | $10.13M | -$1.37B | 2 | 2024-12-23 | |
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | 10,684,638 | $21.53 | $230.04M | $19.55M | 3 | 2024-08-05 | |
| LYB | 10%+ Owner | 41,964,513 | $59.50 | $2.50B | -$82.90M | 3 | 2022-11-30 |
| Climb Bio, Inc. (ELYM) Delisted | 4,209,400 | $5.11 | $21.51M | $10.00M | 1 | 2021-08-16 | |
| Neon Therapeutics, Inc. (NTGN) Delisted | 10%+ Owner | 3,097,913 | — | — | $5.04M | 1 | 2018-07-03 |
Recent Filings · Page 2 of 2
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-13 | LYB | Buy (P) | +2,186,973 | $209.08M | EDGAR |
| 2018-07-03 | Neon Therapeutics, Inc. (NTGN) Delisted | Mixed | +3,097,913 | $5.04M | EDGAR |
| 2016-03-10 | LYB | Mixed | −4,500,000 | -$172.83M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.